HIMX NASDAQ Week ended 31 Jul 2026

Weekly Investor Report

Himax Technologies Inc · Technology · Semiconductors

Open interactive chart View report data
Latest close 12.54 USD
-0.6% latest week
Weekly setup

Mixed setup

The weekly trend is active. Price is 3.7% above the Trend Line and sits at 31.9% of its 52-week range. The latest completed week returned -0.6%, after a -4.6% four-week move. The latest factor snapshot indicates quality is middle-of-the-pack; growth ranks weakly; valuation is expensive relative to peers. Options positioning is volatility with 57/100 conviction, while the latest news-sentiment score is 56/100. Near-term considerations: volume confirmation is below normal; earnings are due in 3d.

Setup score 35 out of 100
Latest Close 12.54 USD 31 Jul 2026
1W Return -0.6% latest completed week
4W Return -4.6% short-term follow-through
12W Return -28.4% quarterly tape
Trend Breadth 48.1% 25 of 52 weeks active
Volume Ratio 0.4x vs 13-week average
What is working
  • The trend backdrop is active with a 16-week active streak.
  • Price is above the Trend Line, keeping the weekly tape constructive.
  • Price is above Fair Value, showing premium demand versus the model.
  • Activity pressure is constructive, supporting the smart-money activity read.
What could go wrong
  • Activity pressure is negative, which weakens the current setup.
  • Next-week expectancy is negative at 42.25% based on similar historical setup states.
  • 2 reversal markers appear in the recent smart-money tape.
  • The share remains more than 20% below its 52-week high.
What to watch next
  • Trend Line remains the key weekly regime level.
  • Activity pressure is the gauge to monitor for confirmation or fade.
  • A volume ratio above 1.5x would show stronger participation in the next move.
Price follow-through -0.6% Latest completed week; four-week move -4.6%. Indicator stack 71/8 Trend and activity pressure are weighted against the latest 12-week confirmation window. Trend backdrop Active The trend backdrop defines the current weekly regime. Patient Capital Quiet Activity-pressure buy-signal status for institutional accumulation timing. Next-Week Expectancy Negative 42.25% Historical one-week expectancy contributes to the evidence score when direction is confirmed. Options pressure Volatility 57/100 conviction; expected move 20.9%. News sentiment 56/100 61 relevant articles in the latest sentiment read. Event risk 3d Next report is scheduled for 06 Aug 2026; event risk rises as the date approaches.
01 · Price action

Where price is—and whether the trend supports it

The weekly trend is active. Price is 3.7% above the Trend Line and sits at 31.9% of its 52-week range. The latest completed week returned -0.6%, after a -4.6% four-week move.

Study the full chart

52-week price path

Price vs Trend Line and Fair Value
Price Trend Line Fair Value
02 · Volume and demand

Is real participation confirming the move?

Latest weekly volume is 0.4x the 13-week average. Participation is below its recent norm, so price strength is not receiving full volume confirmation.

26-week volume confirmation

Bar height shows volume; colour shows the weekly price direction
6 Feb 13 Feb 20 Feb 27 Feb 6 Mar 13 Mar 20 Mar 27 Mar 3 Apr 10 Apr 17 Apr 24 Apr 1 May 8 May 15 May 22 May 29 May 5 Jun 12 Jun 19 Jun 26 Jun 3 Jul 10 Jul 17 Jul 24 Jul 31 Jul
Up week Down week
Demand beneath price

Activity pressure and institutional-style signals

These indicators assess whether participation is improving beneath the headline price move. They are supporting evidence, not proof of institutional buying.

Activity pressure path

Latest 0.6912-week average 0.78

12-week confirmation

Trend active12/12Active trend-backdrop weeks in the latest 12-week window.
Positive pressure8/12Weeks with constructive activity pressure in the latest 12-week window.
Positive leadership12/12Weeks with positive relative leadership in the latest 12-week window.
Activity pressure0.69Current proprietary activity-pressure read.
Buy signals0Accumulation signal count in the latest 12 weeks.
Reversal markers22 reversal markers

No recent accumulation markers. 2 reversal markers.

03 · Momentum and leadership

Is performance persistent—and is the stock leading?

Performance is -4.6% over four weeks, -28.4% over 12 weeks, and 45.0% over one year. The current trend has remained active for 16 consecutive weeks.

Performance by holding period

1W-0.6%
4W-4.6%
12W-28.4%
26W54.2%
52W45.0%
Active trend streak16 weeks
Active weeks in one year25
Trend breadth48.1%

Activity pressure vs relative leadership

Activity pressureRelative leadership
Pressure-0.73Latest activity-pressure read.
Pressure change-363.7%Four-week change in activity pressure.
Leadership12.04Latest relative-leadership reading.
RS change-18.2%Four-week change in relative leadership.
04 · Fundamentals and valuation

What investors are paying for—and the quality behind it

The latest factor snapshot indicates quality is middle-of-the-pack; growth ranks weakly; valuation is expensive relative to peers.

Open full factor analysis
Factor week 02 Aug 2026 Financial statements through 31 Mar 2026 Field coverage 100% Model confidence 95%

Relative factor standing

Higher display scores are better. Each score is converted from the underlying universe rank, where rank 1 is best.

Overall factor strength17/100Blend of value, momentum, and quality. Underlying universe rank 84; rank 1 is best.
Value9/100Relative valuation strength. Underlying universe rank 92; rank 1 is best.
Quality26/100Profitability and accounting quality. Underlying universe rank 75; rank 1 is best.
Momentum89/100Medium-term price momentum. Underlying universe rank 12; rank 1 is best.
Growth2/100Revenue and earnings growth. Underlying universe rank 99; rank 1 is best.
How to read this

Quality and valuation are separate questions

A strong company can still carry a demanding valuation. This report shows profitability, growth, balance-sheet strength, and the price paid for those characteristics separately.

Value-quality framework12/100Value and quality alignment from the Sharemaestro SVQF framework.

Valuation

How much investors are paying for earnings, sales, and cash flow.

P/E
68.5x
Price divided by trailing earnings.
Price / sales
2.7x
Market value relative to trailing revenue.
EV / EBITDA
28.8x
Enterprise value relative to operating cash earnings.
Free-cash-flow yield
5.4%
Free cash flow as a share of enterprise value.

Business quality

Margins and the return generated on invested capital.

Gross margin
30.5%
Gross profit retained from each unit of revenue.
Operating margin
5.5%
Operating profit retained from revenue.
Free-cash-flow margin
13.0%
Free cash flow generated from revenue.
Return on invested capital
5.3%
Operating return generated on invested capital.

Growth and financial strength

Recent business growth and accounting strength.

Revenue growth
-11.0%
Latest one-year revenue growth.
EPS growth
-63.4%
Latest one-year earnings-per-share growth.
Free-cash-flow growth
-19.1%
Latest one-year free-cash-flow growth.
Piotroski F-score
6/9
Nine-point accounting-strength checklist.

Shareholder return and balance sheet

Cash returned to owners and financial leverage.

Dividend yield
2.0%
Cash dividends relative to market value.
Buyback yield
0.2%
Net share repurchases relative to market value.
Shareholder yield
2.2%
Dividend yield plus net buyback yield.
Net debt / EBITDA
-3.4x
Balance-sheet debt relative to operating cash earnings.
05 · Ownership, options, and sentiment

What other market participants are doing

Options, insider transactions, market sentiment, and activity-pressure signals can confirm or challenge the price story. None should be used alone.

Options positioningVolatility

HIMX shows volatility options pressure with a 57/100 conviction score, put-call volume ratio of 0.13, expected move of 20.9%, and Sharemaestro trend signal active.

Conviction57/100
Expected move20.9%
Put/call volume0.13
Pressure86
Speculation40
Volatility96
Trend agreement10
Open options detail
Insider activity-

No recent insider transactions are stored for this company.

News sentiment56/100

Weighted news tone is neutral across 61 relevant articles.

21 positive · 37 neutral · 3 negative
Patient CapitalQuiet

Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.

No recent buy signal
06 · Catalysts and risk

What can move the shares—and how volatile the path has been

Event timing, options-implied movement, drawdown, and weekly return distribution frame the risk around the current setup.

Next earnings3dNext report is scheduled for 06 Aug 2026; event risk rises as the date approaches.
Options expected move20.9%Nearest-chain priced movement where available.
52-week drawdown-49.2%Distance below the 52-week high.
13-week volatility15.8%Standard deviation of weekly returns.

Weekly gains and losses

Latest 26 completed weeks

Each bar is one week. Gains rise above the zero line; losses fall below it. Taller bars mean a larger weekly move.

Weeks higher11 of 2615 weeks finished lower.
Best week+44.5%Week of 8 May.
Worst week-20.5%Week of 26 Jun.
Latest week-0.6%Week of 31 Jul.

Shape of recent returns

Strong gains8
Modest gains3
Flat weeks0
Modest losses9
Sharp losses6
Recent vol15.8%13-week weekly-return volatility.
Base vol11.3%52-week weekly-return volatility.
Up/down split26/26Count of positive and negative weeks in the 52-week window.
Average skew8.9% / -6.3%Average positive week versus average negative week.
07 · Sector and peer context

Is this stock leading—or simply moving with its group?

Sector and industry breadth distinguish company-specific strength from a broad group move.

08 · Evidence and weekly data

The underlying research record

Every top-level statement above should be traceable to a stored market, fundamental, event, or positioning observation.

Weekly tape41/100

Trend, activity pressure, participation, and risk combine to a 41/100 tape read.

 Indicator analysis75/100

Latest 12-week confirmation: trend 12/12, activity pressure 8/12, relative leadership 12/12.

Activity pressure 0.69; 2 reversal markers Next-Week ExpectancyNegative 42.25%

Next-week expectancy is negative with a 42.25% historical one-week setup read.

Adds short-term historical context without overriding trend, activity, or relative leadership. Factors32/100

O'Shaughnessy factor stack blends value, quality, momentum, and confidence.

Buyback Yield rank 40; Small Cap Core rank 90 SVQF12/100

Value and quality alignment from the Sharemaestro SVQF framework.

Composite rank 636.5 of 725 Patient CapitalQuiet

Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.

No recent buy signal Options40/100

HIMX shows volatility options pressure with a 57/100 conviction score, put-call volume ratio of 0.13, expected move of 20.9%, and Sharemaestro trend signal active.

Volatility · Volatility expansion watch · Expected move 20.9% Sentiment56/100

Weighted news tone is neutral across 61 relevant articles.

1 Small-Cap Stock to Own for Decades and 2 We Avoid Insiders50/100

No recent insider transaction evidence is stored.

 Earnings3d

Next report is scheduled for 06 Aug 2026; event risk rises as the date approaches.
WeekCloseReturnTrend LineFair ValuePressureLeadershipVolumeTrend
31 Jul 202612.54 USD-0.6%12.09 USD7.84 USD-0.7312.047.5MOn
24 Jul 202612.62 USD-1.4%11.96 USD7.80 USD-0.6013.725.5MOn
17 Jul 202612.80 USD-16.0%11.82 USD7.76 USD-0.3713.708.0MOn
10 Jul 202615.23 USD15.8%11.66 USD7.72 USD-0.0329.8813.3MOn
3 Jul 202613.15 USD-7.1%11.44 USD7.66 USD0.2814.729.6MOn
26 Jun 202614.16 USD-20.5%11.31 USD7.62 USD0.7524.7913.7MOn
19 Jun 202617.82 USD2.3%11.09 USD7.57 USD1.1050.6011.6MOn
12 Jun 202617.41 USD-11.9%10.73 USD7.49 USD1.3352.5524.1MOn
5 Jun 202619.76 USD-2.4%10.40 USD7.42 USD1.5278.7828.3MOn
29 May 202620.24 USD-2.2%10.01 USD7.34 USD1.5777.5515.1MOn
22 May 202620.70 USD10.4%9.65 USD7.25 USD1.5889.7725.2MOn
15 May 202618.75 USD7.1%9.27 USD7.15 USD1.5876.9841.0MOn
8 May 202617.50 USD44.5%8.95 USD7.07 USD1.5367.0647.7MOn
1 May 202612.11 USD0.2%8.64 USD6.99 USD1.3623.5011.7MOn
How to use this report

This is a completed-week research summary. It explains the available evidence and its conflicts; it does not predict a guaranteed outcome or replace your own risk assessment. Fundamental figures may refer to an earlier financial reporting period, which is shown above.